| Terpyridines as promising antitumor agents: An overview of their discovery and development R Musiol, P Malecki, M Pacholczyk, J Mularski Expert Opinion on Drug Discovery 17 (3), 259-271, 2022 | 22 | 2022 |
| Quinoline alkaloids against neglected tropical diseases R Musiol, K Malarz, J Mularski Current Organic Chemistry 21 (18), 1896-1906, 2017 | 21 | 2017 |
| The p53 stabilizing agent CP-31398 and multi-kinase inhibitors. Designing, synthesizing and screening of styrylquinazoline series J Mularski, K Malarz, M Pacholczyk, R Musiol European Journal of Medicinal Chemistry 163, 610-625, 2019 | 17 | 2019 |
| Novel benzenesulfonate scaffolds with a high anticancer activity and G2/M cell cycle arrest K Malarz, J Mularski, M Kuczak, A Mrozek-Wilczkiewicz, R Musiol Cancers 13 (8), 1790, 2021 | 15 | 2021 |
| The landscape of the anti-kinase activity of the IDH1 inhibitors K Malarz, J Mularski, M Pacholczyk, R Musiol Cancers 12 (3), 536, 2020 | 10 | 2020 |
| Electrolytic copper as cheap and effective catalyst for one-pot triazole synthesis J Mularski, B Czaplińska, W Cieślik, J Bebłot, P Bartczak, R Sitko, ... Scientific Reports 8 (1), 4496, 2018 | 9 | 2018 |
| Styrylquinazoline derivatives as ABL inhibitors selective for different DFG orientations K Malarz, J Mularski, M Pacholczyk, R Musiol Journal of Enzyme Inhibition and Medicinal Chemistry 38 (1), 2201410, 2023 | 1 | 2023 |
| Projektowanie i synteza nowych inhibitorów kinaz tyrozynowych J Mularski Katowice: Uniwersytet Śląski, 2019 | | 2019 |
